[PDF] Mining The Genomes Of Actinomycetes eBook

Author : Johannes Amon
Publisher : Sudwestdeutscher Verlag Fur Hochschulschriften AG
Page : 140 pages
File Size : 37,85 MB
Release : 2010
Category :
ISBN : 9783838117409

GET BOOK

Based on available genome sequences and homology searches with already described systems of close relatives, the up to now mostly unknown repertoire of nitrogen metabolism-related genes in the genus Mycobacterium was discovered and putative pathways and regulatory networks have been constructed and compared. In respect to carbohydrate metabolism, the repertoire of carbohydrate uptake systems in the genus Mycobacterium was studied and predictions about the comparative growth potential of M. smegmatis and Mycobacterium tuberculosis on various carbon sources were provided. In a similar approach, the genome of the industrial relevant probiotic Bifidobacterium longum has been examined for carbohydrate uptake systems. Furthermore, the proteolytic potential of various Corynebacterium species based on all available genome sequences was compared and resulted in a more complete view on the housekeeping protease systems as well as on proteases putatively involved in pathogenicity and virulence of Corynebacterium diphtheriae.

Author : Ravishankar V. Rai
Publisher : Springer Nature
Page : 512 pages
File Size : 13,13 MB
Release : 2022-04-15
Category : Science
ISBN : 9811661324

GET BOOK

This book provides in-depth information about the ecology, diversity and applications of Actinomycetes. The book is divided into two major parts. The first part discusses the diversity, chemical biology and ecology of Actinomycetes. It also covers the discovery of natural products from soil, endophytic and marine-derived Actinomycetes. It includes natural product discovery, chemical biology, new methods for discovering secondary metabolites, structure elucidation and biosynthetic research of natural products. The chapters in this part focus on the effects of biological and chemical elicitation at molecular level on secondary metabolism in Actinomycetes. The second part of the book discusses genomic and synthetic biology approaches in Actinomycetes drug discovery. This part includes chapters focused on the application of metabolic engineering to optimize natural product synthesis and the use of omics data in engineering of regulatory genes. It covers the advanced tools of synthetic biology and metabolic engineering including cluster assembly, CRISPR/Cas9 technologies, and chassis strain development for natural product overproduction in Actinomycetes. It describes the use of bioinformatics tools for reprogramming of biosynthetic pathways through polyketide synthase and non-ribosomal peptide synthetase engineering. These advanced genomic and molecular tools are expected to accelerate the discovery and development of new natural products from Actinomycetes with medicinal and other industrial applications. The book is useful to researchers and students in the field of microbiology, pharmaceutical sciences and drug discovery.

Author : Evi Stegmann
Publisher :
Page : 362 pages
File Size : 33,12 MB
Release : 2020-09-04
Category :
ISBN : 9783039369102

GET BOOK

Beyond being the most important natural compound source, actinomycetes are the origin of up to two-thirds of all clinically used antibiotics. Currently, new antimicrobials are urgently needed, as infections caused by antibiotic-resistant pathogens are on the rise. In the identification of new antibiotics, many scientists are currently investigating biosynthetic aspects of antibiotic production in actinomycetes. Since the emergence of next-generation sequencing technologies, the field of antibiotics research has experienced a remarkable revival. These bacteria have the potential to produce more antibiotics than previously thought possible. Some antibiotics are produced in standard media, while others require the presence of a specific signaling molecule in the medium. Others, however, are only produced when the native regulation of the biosynthesis gene cluster is overruled. This book covers topics in the field of antibiotic-producing actinomycetes. The following tops are addressed: - Approaches to access novel antibiotic producers for novel natural compounds - Omics and genome mining approaches for the discovery of novel natural compounds - Analyses and genetic engineering of antibiotic biosynthesis - Regulation of the secondary metabolism in actinomycetes

Author : Joachim Wink
Publisher : Springer
Page : 398 pages
File Size : 31,40 MB
Release : 2017-10-19
Category : Science
ISBN : 3319603396

GET BOOK

This book provides in-depth insights into the biology, taxonomy, genetics, physiology and biotechnological applications of Actinobacteria. It especially focuses on the latter, reviewing the wide variety of actinobacterial bioactive molecules and their benefits for diverse industrial applications such as agriculture, aquaculture, biofuel production and food technology. Actinobacteria are one of the most promising sources of small bioactive molecules and it is estimated that only a small percentage of actinobacterial bioactive chemicals have been discovered to date. Identifying new diverse gene clusters of biotechnological relevance in the genome of Actinobacteria will be crucial to developing advanced applications for pharmaceutical, industrial and agricultural purposes. The book offers a unique resource for all graduate students, researchers and practitioners in the fields of microbiology, microbial biotechnology, and the genetic engineering of Actinobacteria.

Author : Dirk Tischler
Publisher : Frontiers Media SA
Page : 236 pages
File Size : 28,55 MB
Release : 2019-08-12
Category :
ISBN : 2889459225

GET BOOK

Actinobacteria (Actinomycetes) represent one of the largest and most diverse phyla among Bacteria. The remarkable diversity is displayed by various lifestyles, distinct morphologies, a wide spectrum of physiological and metabolic activities, as well as genetics. Interestingly, most Actinobacteria have a high GC-content (ranging from 51% to >70%) and belong to Gram-positive or Gram-variable type microbes. Many species are well known for large genomes which may be of linear style as in case of rhodococci or circular. Many of those harbor linear megaplasmids as a kind of genetic storage device. Frequently gene redundancy is reported and in most cases the evolutionary history or a functional role remains enigmatic. Nevertheless these large genomes and megaplasmids provide access to a number of potential (homologous) biocatalysts which await elucidation. Actinobacteria are well known for their biotechnological potential which is exemplarily described for amino acid producing Corynebacteria, secondary metabolite producing Streptomyces, pathogenic targets as Nocardia and Mycobacteria, carotenoid building Micrococcus strains, acid fermenting Propionibacteria, health and food related Bifidobacterium strains, rubber degrading Gordonia species, and organic pollutant degrading rhodococci among others. In many cases individual pathways or enzymes can be modified or recombinantly employed for biocatalysis. Even some genetic tools to work directly in those microbes have been successfully used as for example in Corynebacterium or in Rhodococcus species. During the last decade more and more genomes have been sequenced and made available for data mining and become accessible by state of the art genomic manipulation methods as minimal genomes, knock-out or artificial evolution. With respect to this large and ancient phylum many questions can be asked either from a scientific or industrial point of view. In order to provide some crystallization points we like to raise some examples as follows. How small can be an actinobacterial genome? What is the driving force to comprise large and repetitive genomes/megaplasmids? What is needed to generate an actinobacterial power house for industry? Can we annotate novel biocatalysts from scratch and improve functional annotation? What are common and different features with respect to other bacteria and/or fungi? How many novel antibiotics are hidden among Actinobacteria? Is there more potential among extremophile members or are they only specialized? Here especially the production of natural compounds is of high interest.

Author : Loganathan Karthik
Publisher : Springer Nature
Page : 285 pages
File Size : 14,2 MB
Release : 2022-01-29
Category : Science
ISBN : 9811658358

GET BOOK

This book summarizes the basics of actinobacteria, from microbiology to synthetic biology. It focuses on diversity, NRPS, sesquiterpenes, lantipeptide, bioinformatics apparatuses, cloning, CRISPR, reverse engineering, FDA supported medications, and marine actinobacteria. It also covers the latest trends in drug discovery from actinobacteria, and introduces several recently developed bioinformatics and synthetic biology tools to explore new antibiotics from actinobacteria. Many natural products such as polyketides, isoprenoids, phenazines, peptides, indolocarbarbazoles, sterols, and others have been isolated and characterized from actinobacteria. Some products are synthesized by the non-ribosomal peptide synthetases (NRPSs), polyketide synthases (PKSs), or other functional genes. Although genome sequencing has uncovered the differing qualities of these chemicals, recognizing new items and their biosynthetic pathways is still under examination. Cryptic metabolic pathways have been explored using molecular techniques or culture-dependent approaches. In recent years, researchers’ primary interest is to identify the specific conditions or agents that wake the cryptic antibiotics. Several bioinformatics and synthetic biology tools were developed to explore new antibiotics from actinobacteria. The book comprises 14 chapters with different aspects of application and utilization of actinomycetes from the microbiology; systems biology, pharmacology of natural products, bioinformatics, actinomycete and its diversity, CRISPR, artificial Intelligence, synthetic biology, metabolic engineering, expressional studies, and biosynthetic gene clusters. The book delivers useful information on actinomyces to researchers, novices in genome designing, specialists, clinicians, policymakers, and professionals.

Author : Dharumadurai Dhanasekaran
Publisher : BoD – Books on Demand
Page : 401 pages
File Size : 47,33 MB
Release : 2016-02-11
Category : Science
ISBN : 9535122487

GET BOOK

This book presents an introductory overview of Actinobacteria with three main divisions: taxonomic principles, bioprospecting, and agriculture and industrial utility, which covers isolation, cultivation methods, and identification of Actinobacteria and production and biotechnological potential of antibacterial compounds and enzymes from Actinobacteria. Moreover, this book also provides a comprehensive account on plant growth-promoting (PGP) and pollutant degrading ability of Actinobacteria and the exploitation of Actinobacteria as ecofriendly nanofactories for biosynthesis of nanoparticles, such as gold and silver. This book will be beneficial for the graduate students, teachers, researchers, biotechnologists, and other professionals, who are interested to fortify and expand their knowledge about Actinobacteria in the field of Microbiology, Biotechnology, Biomedical Science, Plant Science, Agriculture, Plant pathology, Environmental Science, etc.

Author : Yanyan Li
Publisher : Springer
Page : 113 pages
File Size : 19,87 MB
Release : 2014-10-21
Category : Medical
ISBN : 1493910108

GET BOOK

Lasso peptides form a growing family of fascinating ribosomally-synthesized and post-translationally modified peptides produced by bacteria. They contain 15 to 24 residues and share a unique interlocked topology that involves an N-terminal 7 to 9-residue macrolactam ring where the C-terminal tail is threaded and irreversibly trapped. The ring results from the condensation of the N-terminal amino group with a side-chain carboxylate of a glutamate at position 8 or 9, or an aspartate at position 7, 8 or 9. The trapping of the tail involves bulky amino acids located in the tail below and above the ring and/or disulfide bridges connecting the ring and the tail. Lasso peptides are subdivided into three subtypes depending on the absence (class II) or presence of one (class III) or two (class I) disulfide bridges. The lasso topology results in highly compact structures that give to lasso peptides an extraordinary stability towards both protease degradation and denaturing conditions. Lasso peptides are generally receptor antagonists, enzyme inhibitors and/or antibacterial or antiviral (anti-HIV) agents. The lasso scaffold and the associated biological activities shown by lasso peptides on different key targets make them promising molecules with high therapeutic potential. Their application in drug design has been exemplified by the development of an integrin antagonist based on a lasso peptide scaffold. The biosynthesis machinery of lasso peptides is therefore of high biotechnological interest, especially since such highly compact and stable structures have to date revealed inaccessible by peptide synthesis. Lasso peptides are produced from a linear precursor LasA, which undergoes a maturation process involving several steps, in particular cleavage of the leader peptide and cyclization. The post-translational modifications are ensured by a dedicated enzymatic machinery, which is composed of an ATP-dependent cysteine protease (LasB) and a lactam synthetase (LasC) that form an enzymatic complex called lasso synthetase. Microcin J25, produced by Escherichia coli AY25, is the archetype of lasso peptides and the most extensively studied. To date only around forty lasso peptides have been isolated, but genome mining approaches have revealed that they are widely distributed among Proteobacteria and Actinobacteria, particularly in Streptomyces, making available a rich resource of novel lasso peptides and enzyme machineries towards lasso topologies.